Dopamine-2 Receptor Antagonist [EPC]

5425 reported adverse events

Drugs of this class: DROPERIDOL AMISULPRIDE

These side effects are most commonly reported by patients taking drugs of the Dopamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 587
1 DRUG INTERACTION 354
2 NEUTROPENIA 283
3 TOXICITY TO VARIOUS AGENTS 258
4 WEIGHT INCREASED 256
5 ELECTROCARDIOGRAM QT PROLONGED 255
6 SCHIZOPHRENIA 244
7 LEUKOPENIA 232
8 AKATHISIA 216
9 EXTRAPYRAMIDAL DISORDER 215
See all common reactions for Dopamine-2 Receptor Antagonist [EPC]

Drugs of the Dopamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF MEASLES ANTIBODY POSITIVE 10 0.8333
1 DELAYED VISUAL MATURATION 5 0.3571
2 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 135 0.2523
3 REFUSAL OF EXAMINATION 22 0.1897
4 RUBELLA ANTIBODY POSITIVE 10 0.1852
5 ANTIPSYCHOTIC DRUG LEVEL DECREASED 50 0.1235
6 DIFFUSE LARGE B-CELL LYMPHOMA STAGE II 6 0.1091
7 BLADDER TRABECULATION 6 0.0952
8 TOBACCO INTERACTION 8 0.0941
9 DISINHIBITION 123 0.0882
See all enriched reactions for Dopamine-2 Receptor Antagonist [EPC]